Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Co-amilofruse 5mg/40mg tablets
0202040B0AAAAAA
|
Co-amilofruse | Co-amilofruse (Amiloride hydrochloride/frusemide) | Cardiovascular System | 32,828 |
|
Co-amilofruse 2.5mg/20mg tablets
0202040B0AAABAB
|
Co-amilofruse | Co-amilofruse (Amiloride hydrochloride/frusemide) | Cardiovascular System | 21,292 |
|
Co-amilofruse 10mg/80mg tablets
0202040B0AAACAC
|
Co-amilofruse | Co-amilofruse (Amiloride hydrochloride/frusemide) | Cardiovascular System | 163 |
|
Co-amilofruse 5mg/40mg/5ml oral liquid
0202040B0AAAHAH
|
Co-amilofruse | Co-amilofruse (Amiloride hydrochloride/frusemide) | Cardiovascular System | 2 |
|
Amiloride 10mg/5ml / Furosemide 125mg/5ml oral liquid
0202040B0AAALAL
|
Co-amilofruse | Co-amilofruse (Amiloride hydrochloride/frusemide) | Cardiovascular System | No data available |
|
Co-amilofruse 1.25mg/10mg/5ml oral liquid
0202040B0AAAMAM
|
Co-amilofruse | Co-amilofruse (Amiloride hydrochloride/frusemide) | Cardiovascular System | No data available |
|
Co-amilofruse 10mg/80mg/5ml oral liquid
0202040B0AAAIAI
|
Co-amilofruse | Co-amilofruse (Amiloride hydrochloride/frusemide) | Cardiovascular System | No data available |
|
Co-amilofruse 2.5mg/20mg/5ml oral liquid
0202040B0AAAJAJ
|
Co-amilofruse | Co-amilofruse (Amiloride hydrochloride/frusemide) | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.